Optimi Health Announces Closing of Strategic Non-Brokered Private Placement
11 oct. 2022 09h00 HE
|
Optimi Health Corp.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. Highlights: ...
LA Goes Psychedelic September 30
27 sept. 2022 09h35 HE
|
The Psychedelic Institute
LOS ANGELES, Sept. 27, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – The Psychedelic Institute is convening the first major psychedelic conference to be held in Los Angeles on Friday, September 30, at...
Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
22 sept. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
MindSite News Launches Live Conversation Series on Psychedelics and Mental Health
20 sept. 2022 11h00 HE
|
MindSite News
OAKLAND, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- MindSite News—the only news site dedicated exclusively to reporting on mental health in America—is launching a live public conversation series...
Does Microdosing Impact Meditation? New Study From Beckley Foundation and Quantified Citizen Investigates
15 sept. 2022 13h15 HE
|
Quantified Citizen
VANCOUVER, British Columbia, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Microdosing and Meditation Study, led by Beckley Foundation in collaboration with Psychedelic Data Society and Quantified Citizen...
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
08 sept. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed...
Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global
07 sept. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Heroic Hearts Project and Maya Partner to Establish Advanced Data Capture Protocols for Veterans Seeking Psychedelic Treatments
01 sept. 2022 10h15 HE
|
Heroic Hearts Project
NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Today, Heroic Hearts Project and Maya PBC announced their partnership in support of aggregating clinical evidence for health outcomes achieved through...
Optimi Health Provides Progress Report On Year Of Commercialization
01 sept. 2022 09h00 HE
|
Optimi Health Corp.
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE:...
Optimi Health Enters Into International Collaborative Research and Supply Agreement With Promises Innovative Recovery Center
30 août 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...